-+ 0.00%
-+ 0.00%
-+ 0.00%

CNS Pharmaceuticals director Michal Fisher acquires $10,000 of common shares

PUBT·08/18/2026 13:01:41
Listen to the news
CNS Pharmaceuticals director Michal Fisher acquires $10,000 of common shares
  • CNS Pharmaceuticals director Michal Fisher bought 2,000 common shares at USD 5 per share.
  • Direct holding rose to 2,000 shares following the purchase.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CNS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-006553), on August 18, 2026, and is solely responsible for the information contained therein.